한빛사논문
Kaho Shionoya 1,2,3,12, Jae-Hyun Park 4,5,12, Toru Ekimoto 6, Junko S. Takeuchi 7, Junki Mifune 3, Takeshi Morita 3, Naito Ishimoto 4, Haruka Umezawa 4, Kenichiro Yamamoto 6, Chisa Kobayashi 1,2,3, Atsuto Kusunoki 3, Norimichi Nomura 8, So Iwata 8,9, Masamichi Muramatsu 1,10, Jeremy R. H. Tame 4, Mitsunori Ikeguchi 6,11, Sam-Yong Park 4,* & Koichi Watashi 1,2,3,*
1Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
2Graduate School of Science and Technology, Tokyo University of Science, Chiba, Japan.
3Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.
4Drug Design Laboratory, Graduate School of Medical Life Science, Yokohama City University, Kanagawa, Japan.
5Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
6Computational Life Science Laboratory, Graduate School of Medical Life Science, Yokohama City University, Kanagawa, Japan.
7Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
8Department of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
9RIKEN SPring-8 Center, Hyogo, Japan.
10Department of Infectious Disease Research, Foundation for Biomedical Research and Innovation at Kobe, Hyogo, Japan.
11HPC- and AI-driven Drug Development Platform Division, Center for Computational Science, RIKEN, Kanagawa, Japan.
12These authors contributed equally: Kaho Shionoya, Jae-Hyun Park.
*Corresponding authors: correspondence to Sam-Yong Park or Koichi Watashi
Abstract
논문정보
관련 링크
연구자 키워드
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기